Latest News

Glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life, study suggests

Many glioblastoma patients treated with bevacizumab (AvastinŽ) have significant deterioration in neurocognitive function, symptoms and quality of life.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Abnormal brain rhythms tied to problems with thinking in schizophrenia

  • Neuropathy: Relief for diabetics with painful condition

  • Exposure to endocrine disruptors during pregnancy affects the brain two generations later, rat study shows

  • Autistic features linked to prenatal exposure to commonly found fire retardants, phthalates

  • Seven strategies to advance women in science

  • Mutation in APC2 gene causes Sotos features

  • From chick to bedside: Removing the Wnt barrier

  • Drug to control appetite could also fight anxiety

  • Oxytocin nasal spray causes men to eat fewer calories

  • Human brains age less than previously thought

  •